论文部分内容阅读
目的:探讨干扰素在重度淋巴水肿综合治疗中的临床疗效。方法:将58例重度淋巴水肿患者分为两组:对照组及加用干扰素治疗组。治疗时间为2个月。结果:对照组及干扰素治疗组的缓解率为100%。对照组显效率及有效率为别为42.9%及57.1%,干扰素治疗组显效率及有效率分别为63.3%和36.7%,统计学分析,两组之间有显著性差异(P<0.05)。结论:加用干扰素的综合治疗可提高重度淋巴水肿的缓解率。
Objective: To investigate the clinical efficacy of interferon in the treatment of severe lymphedema. Methods: 58 cases of severe lymphedema were divided into two groups: control group and interferon plus treatment group. Treatment time is 2 months. Results: The response rate of the control group and interferon treatment group was 100%. The effective rate and effective rate of the control group were 42.9% and 57.1% respectively. The effective rate and effective rate of the interferon treatment group were 63.3% and 36.7% respectively. There was significant difference between the two groups (P <0.05) . Conclusion: Combined treatment with interferon can improve the remission rate of severe lymphedema.